238 related articles for article (PubMed ID: 6370541)
1. Clinical pharmacokinetics of labetalol.
McNeil JJ; Louis WJ
Clin Pharmacokinet; 1984; 9(2):157-67. PubMed ID: 6370541
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of labetalol in healthy volunteers.
Kanto J; Allonen H; Kleimola T; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):41-4. PubMed ID: 7203731
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
Donnelly R; Macphee GJ
Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
[TBL] [Abstract][Full Text] [Related]
5. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
[TBL] [Abstract][Full Text] [Related]
6. Decreased first-pass metabolism of labetalol in chronic liver disease.
Homeida M; Jackson L; Roberts CJ
Br Med J; 1978 Oct; 2(6144):1048-50. PubMed ID: 709214
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
9. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP; Bloomfield SS
Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
Sanders GL; Davies DM; Rawlins MD
Br J Clin Pharmacol; 1980 Aug; 10(2):121-6. PubMed ID: 6252915
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
Elliott HL; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of labetalol increases with age.
Kelly JG; McGarry K; O'Malley K; O'Brien ET
Br J Clin Pharmacol; 1982 Aug; 14(2):304-5. PubMed ID: 7104187
[TBL] [Abstract][Full Text] [Related]
13. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
14. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
15. Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
Walstad RA; Berg KJ; Wessel-Aas T; Nilsen OG
Acta Med Scand Suppl; 1982; 665():135-41. PubMed ID: 6961760
[TBL] [Abstract][Full Text] [Related]
16. Labetalol disposition and concentration-effect relationships during pregnancy.
Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
[TBL] [Abstract][Full Text] [Related]
17. The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1984 Sep; 18(3):393-400. PubMed ID: 6487478
[TBL] [Abstract][Full Text] [Related]
18. Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol.
Maronde RF; Robinson D; Vlachakis ND; Barr JW; Chung M; Zampaglione N; Medakovic M
Am J Med; 1983 Oct; 75(4A):40-6. PubMed ID: 6356898
[TBL] [Abstract][Full Text] [Related]
19. Elimination kinetics of labetalol in severe renal failure.
Wood AJ; Ferry DG; Bailey RR
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):81S-86S. PubMed ID: 7093103
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of amiodarone.
Latini R; Tognoni G; Kates RE
Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
